Phase 4 APL Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
CHAPLE Disease
Regeneron Pharmaceuticals5 enrolled1 locationNCT07142343
Recruiting
Phase 4
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Gastric Intestinal Metaplasia
Yongquan Shi196 enrolled6 locationsNCT06610760
Recruiting
Phase 4
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
Antiphospholipid (aPL)-PositiveThrombocytopaenia
Peking University First Hospital84 enrolled10 locationsNCT06722586
Recruiting
Phase 4
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
Gastric Intestinal Metaplasia
Yongquan Shi400 enrolled1 locationNCT06610266
Completed
Phase 3Phase 4
A prospective, randomised controlled trial of auto-titrating Continuous positive airway pressure treatment for Obstructive Sleep Apnoea after acute Quadriplegia
Acute tetraplegia
Institute for Breathing and Sleep150 enrolled2 locationsACTRN12605000799651